Shanghai Junshi Biosciences Co Ltd (688180) — Working Capital to Net Assets Ratio
Shanghai Junshi Biosciences Co Ltd (688180) has a Working Capital to Net Assets ratio of 27.0% as of December 2025. Working capital of CN¥1.68 Billion (current assets of CN¥4.46 Billion minus current liabilities of CN¥2.78 Billion) is measured against net assets of CN¥6.22 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shanghai Junshi Biosciences Co Ltd (688180) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Junshi Biosciences Co Ltd Working Capital to Net Assets (2014–2025)
This chart shows how Shanghai Junshi Biosciences Co Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 27.0%, reflecting working capital of CN¥1.68 Billion against net assets of CN¥6.22 Billion CNY. See Shanghai Junshi Biosciences Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Shanghai Junshi Biosciences Co Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Junshi Biosciences Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Shanghai Junshi Biosciences Co Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.0% | CN¥1.68 Billion | CN¥6.22 Billion | CN¥4.46 Billion | CN¥2.78 Billion | ▼ -2.4 pp |
| 2024 | 29.4% | CN¥1.75 Billion | CN¥5.95 Billion | CN¥4.28 Billion | CN¥2.53 Billion | ▼ -12.9 pp |
| 2023 | 42.3% | CN¥3.10 Billion | CN¥7.32 Billion | CN¥5.57 Billion | CN¥2.48 Billion | ▼ -13.2 pp |
| 2022 | 55.4% | CN¥5.43 Billion | CN¥9.79 Billion | CN¥7.20 Billion | CN¥1.77 Billion | ▲ +9.5 pp |
| 2021 | 46.0% | CN¥3.83 Billion | CN¥8.33 Billion | CN¥5.83 Billion | CN¥2.00 Billion | ▼ -9.3 pp |
| 2020 | 55.2% | CN¥3.23 Billion | CN¥5.84 Billion | CN¥4.70 Billion | CN¥1.47 Billion | ▲ +11.5 pp |
| 2019 | 43.7% | CN¥1.31 Billion | CN¥2.99 Billion | CN¥1.91 Billion | CN¥605.38 Million | ▼ -29.8 pp |
| 2018 | 73.4% | CN¥2.44 Billion | CN¥3.32 Billion | CN¥2.91 Billion | CN¥471.06 Million | ▲ +33.0 pp |
| 2017 | 40.4% | CN¥452.45 Million | CN¥1.12 Billion | CN¥511.01 Million | CN¥58.56 Million | ▼ -6.3 pp |
| 2016 | 46.7% | CN¥525.95 Million | CN¥1.13 Billion | CN¥544.91 Million | CN¥18.96 Million | ▼ -32.5 pp |
| 2015 | 79.2% | CN¥486.43 Million | CN¥614.22 Million | CN¥500.59 Million | CN¥14.16 Million | ▼ -2.2 pp |
| 2014 | 81.4% | CN¥260.45 Million | CN¥319.87 Million | CN¥273.52 Million | CN¥13.07 Million | — |